Intermountain Liver Disease and Transplant Center

Murray, Utah 84107

0 studies enrolling now · 5 studies all time

What they study most

Hemostasis, Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, Nonalcoholic Steatohepatitis (NASH)

Studies at this site

• Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Completed
• Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis — Stopped early
• Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis — Completed
• Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH) — Completed
• HEMOBLAST Pivotal Clinical Investigation — Completed